- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 718.35M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $120.65M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $120.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $202.65M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $204.95M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $133.03M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $132.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $29.86M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $35.22M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $336.74M |
| Total Assets | Q1 2025 · Mar 31, 2024 | $343.52M |
| Stock Repurchased | Q1 2025 · Apr 30, 2024 | $4K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 721.67M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $1.22M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.61M |
| Net Income | Q1 2025 · Mar 31, 2024 | $5.04M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$168K |
| Revenue | Q1 2025 · Mar 31, 2024 | $9.25M |